85-1793-12　［取扱停止］TC HSD 21 (5-[(3-Bromo-4-hydroxyphenyl)methyle­ne]-3-(4-methoxyphenyl)-2-thioxo-4-thiazolidinone) 10mg　145694

特徴

• Potent 17beta-hydroxysteroid dehydrogenase type 3 (17beta-HSD3) inhibitor (IC50 values are 6 and 40nm at human and mouse 17beta-HSD3 respectively). Displays no activity at 17beta-HSD1, 17beta-HSD2, ERalpha, androgen receptors or glucocorticoid receptors.
• Sequence:C17H12BrNO3S2
• Solubility:DMSO (~100mM)
• Molecular Weight:~422.32
• Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile buffer or ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：10mg
• Grade：Highly Purified
• Purity：~99% (HPLC)
• Form：Supplied as a yellow solid.
• Molecular Formula：C17H12BrNO3S2
• Molecular Weight Non Ab：422.32
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]